861 studies found for:    Huntington's Disease
Show Display Options
Rank Status Study
21 Completed Impact of Xenazine(Tetrabenazine)on Gait and Functional Activity in Individuals With Huntington's Disease
Condition: Huntington's Disease
Intervention:
22 Completed Deep Brain Stimulation of the Globus Pallidus in Huntington's Disease
Condition: Huntington's Disease
Intervention: Procedure: Stimulation
23 Completed Neuroprotection by Cannabinoids in Huntington's Disease
Condition: Huntington's Disease
Interventions: Drug: delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD);   Drug: Placebo
24 Completed Premanifest Huntington's Disease: Creatine Safety & Tolerability Extension Study
Condition: Huntington's Disease
Intervention: Drug: Creatine Monohydrate
25 Completed Premanifest Huntington's Disease Extension Study II: Creatine Safety & Tolerability
Condition: Huntington's Disease
Intervention: Drug: Creatine monohydrate
26 Recruiting Creatine Safety, Tolerability, & Efficacy in Huntington's Disease (CREST-E)
Condition: Huntington's Disease
Interventions: Drug: Creatine Monohydrate;   Drug: Placebo
27 Completed
Has Results
Creatine Safety & Tolerability in Huntington's Disease
Condition: Huntington's Disease (HD)
Intervention: Drug: Creatine monohydrate
28 Recruiting Study Evaluating The Safety, Tolerability And Brain Function Of 2 Doses Of PF-0254920 In Subjects With Early Huntington's Disease
Condition: Huntington's Disease
Interventions: Drug: PF-02545920;   Drug: Placebo
29 Active, not recruiting Effects of EGCG (Epigallocatechin Gallate) in Huntington's Disease (ETON-Study)
Condition: Huntington Disease
Interventions: Drug: (2)-epigallocatechin-3-gallate (EGCG);   Drug: Placebo
30 Completed
Has Results
Examination of Quantitative Electroencephalographic (QEEG) Biomarkers in Huntington's Disease
Condition: Huntington's Disease
Intervention:
31 Completed
Has Results
Pilot Study of Minocycline in Huntington's Disease
Condition: Huntington Disease
Interventions: Drug: minocycline;   Drug: Matching placebo
32 Active, not recruiting Open-label Extension Study of Pridopidine (ACR16) in the Symptomatic Treatment of Huntington Disease
Condition: Huntington Disease
Intervention: Drug: pridopidine
33 Unknown  Ursodiol in Huntington's Disease
Condition: Huntington Disease
Interventions: Drug: ursodiol;   Drug: placebo
34 Completed Family Health After Predictive Huntington Disease (HD) Testing
Condition: Huntington Disease
Intervention: Genetic: Mutation in the gene
35 Recruiting REGISTRY-JHD - an Observational Study of the European Huntington's Disease Network (EHDN)
Condition: Huntington Disease, Juvenile
Intervention:
36 Completed TREND-HD - A Trial of Ethyl-EPA (Miraxion™) in Treating Mild to Moderate Huntington's Disease
Condition: Huntington Disease
Intervention: Drug: Ethyl-EPA (Miraxion™)
37 Completed
Has Results
Atomoxetine and Huntington's Disease
Conditions: Huntington Disease;   Chorea
Interventions: Drug: atomoxetine;   Drug: Matching Placebo
38 Completed A Study of ACR16 for the Treatment of Patients With Huntington's Disease
Condition: Huntington Disease
Interventions: Drug: ACR16 10 mg;   Drug: ACR16 22.5 mg;   Drug: ACR16 45 mg;   Other: Placebo
39 Not yet recruiting Randomized, Placebo Controlled Study Of The Efficacy And Safety Of PF-02545920 In Subjects With Huntington's Disease
Condition: Huntington's Disease
Interventions: Drug: PF-02545920;   Other: Placebo
40 Recruiting A Pre-Cellular Therapy Observational Study in Early Huntington's Disease
Condition: Huntington Disease
Intervention:

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years